Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02)

• 資料種別: 記事
• タイトル: Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02)
• 著者標目: Tsukasa Hasegawa; Ryo Ariyasu; https://orcid.org/0000-0003-4393-9176; Hisashi Tanaka; Ryota Saito; Yosuke Kawashima; Atsushi Horiike; Toshio Sakatani; Takehiro Tozuka; https://orcid.org/0000-0002-3774-8915; Jun Shiihara; Masafumi Saiki; Yuichi Tambo; Tomoaki Sonoda; Akito Miyazaki; Shinya Uematsu; Yuko Tsuchiya-Kawano; Noriko Yanagitani; Makoto Nishino
• 出版年月日等: 2023-05-27
• 出版年（W3CDTF）: 2023-05-27
• タイトル（掲載誌）: Cancer Chemotherapy and Pharmacology
• 巻号年月日等（掲載誌）: 92
• 掲載巻: 92
• 掲載ページ: 29-37
• 掲載年月日（W3CDTF）: 2023-05-27
• ISSN（掲載誌）: 03445704
• 出版事項（掲載誌）: Springer Science and Business Media LLC
• 件名標目: Consolidation Chemotherapy; Lung Neoplasms; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Disease Progression; Humans; Chemoradiotherapy; Retrospective Studies; Neoplasm Staging
• 対象利用者: 一般
• 標準番号（その他）: PMID : 37243795
• DOI: 10.1007/s00280-023-04547-2
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/

• 要約等: For patients with locally advanced non-small-cell lung cancer (LA-NSCLC) that progressed after definitive chemoradiotherapy (CRT) and durvalumab conso...